From Plasma to Healing: The Intricate Journey of Producing Immune Globulin Medications

In this episode, we will discuss the intricate process of producing immune globulin products, hereafter referred to as IG products.

Today, we have guest speaker Keith Berman. Keith has worked in the plasma therapeutics and blood therapies industry in a career spanning over three decades. He holds a bachelor’s degree in biological science from UC Berkeley, an MBA in marketing and an MPH in health services management from UCLA.

Beginning his career in the late 1980s, Keith started at what is now Takeda, where he supported IG product development and was involved in the successful U.S. launch of Gammagard. His knowledge and experience in IG development, usage and reimbursement have made him a trusted advisor in the industry.

In addition to his consultancy work, since 1989, Keith has served as editor and writer of International Blood/Plasma News, a monthly newsletter that covers the blood and plasma products industry. 

Support the show